Clearside Biomedical CEO George Lasezkay's 2023 pay stays at $1.5M
Clearside Biomedical reports 2023 executive compensation
By ExecPay News
Published: April 26, 2024
Clearside Biomedical reported fiscal year 2023 executive compensation information on April 26, 2024.
In 2023, three executives at Clearside Biomedical received on average a compensation package of $919K, a 18% decrease compared to previous year.
Average pay of disclosed executives at Clearside Biomedical
George Lasezkay, Chief Executive Officer, received $1.5M in total, which is about the same as previous year. 46% of Lasezkay's compensation, or $702K, was in option awards. Lasezkay also received $274K in non-equity incentive plan, $547K in salary, as well as $15K in other compensation.
Charles A. Deignan, Chief Financial Officer, received a compensation package of $854K, which decreased by 2% compared to previous year. 48% of the compensation package, or $409K, was in salary.
Thomas Ciulla, Chief Medical Officer, earned $364K in 2023, a 61% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2024.